Association between low estrogen receptor positive breast cancer and staining performance

Estrogen receptor (ER) expression in breast carcinomas, determined by immunohistochemistry, indicates statistically significant benefit to endocrine therapy in patients with tumors expressing ER in ≥1% of tumor cells. Rare cases with low ER expression (1–10%) lead to the dilemma of treating these tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruana, Dennis, Wei, Wei, Martinez-Morilla, Sandra, Rimm, David L., Reisenbichler, Emily S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002746/
https://www.ncbi.nlm.nih.gov/pubmed/32047851
http://dx.doi.org/10.1038/s41523-020-0146-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002746/
https://www.ncbi.nlm.nih.gov/pubmed/32047851
http://dx.doi.org/10.1038/s41523-020-0146-2

Ejemplares similares